Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.

Michael Marks ORCID logo ; Sarah Gwyn ; Hilary Toloka ; Christian Kositz ORCID logo ; James Asugeni ; Rowena Asugeni ; Jason Diau ; John M Kaldor ; Lucia Romani ; Michelle Redman-MacLaren ; +5 more... David MacLaren ; Anthony W Solomon ; David CW Mabey ORCID logo ; Andrew C Steer ; Diana Martin ; (2020) Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (12). pp. 3226-3228. ISSN 1058-4838 DOI: 10.1093/cid/ciaa584
Copy

The prevalence of antibodies to Strongyloides stercoralis was measured in 0-12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collateral benefits of ivermectin MDA in this setting.
Item Type Article
Elements ID 147875
Date Deposited 11 Nov 2020 13:01

Explore Further

picture_as_pdf
picture_as_pdf
ciaa584.pdf
subject
Published Version
Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads